Roche’s CellCept was safe, but lacked clinical benefits, during short-term use by patients with…
Ana Pena, PhD
Ana is a molecular biologist with a passion for discovery and communication. As a science writer, she looks for connecting the public, in particular patients and healthcare providers, with clear and quality information about the latest medical advances. Ana holds a Ph.D. in Biomedical Sciences from the University of Lisbon, Portugal, where she specialized in infectious diseases, epigenetics, and gene expression.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Ana Pena, PhD
Neuron-like cells derived from a Batten patient’s skin cells may be a suitable way of investigating the…
Therapeutic approaches that target production of a protein called progranulin in specific brain cells may help preserve brain function in…
Research into the CLN3 protein, whose nonfunctional form underlies juvenile Batten disease, may be compromised by…
Several compounds were able to correct defects in the brain caused by juvenile neuronal ceroid…
Chinese researchers used an advanced genetic sequencing technique to identify two new pathogenic variants of the CLN8 gene in…
Gene therapy directly targeting a specific type of neuron in the retina of the eye was able to…